China Biologic Produ
(CBPO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 114,106 | 96,113 | 76,861 | 65,972 | 31,383 |
| Depreciation Amortization | 9,034 | 7,748 | 7,462 | 8,881 | 29,405 |
| Income taxes - deferred | -170 | 3,484 | 113 | 1,127 | -2,595 |
| Accounts receivable | -7,146 | -2,191 | -5,667 | 5,690 | -6,127 |
| Accounts payable and accrued liabilities | 5,349 | 405 | 1,622 | -2,185 | 432 |
| Other Working Capital | -28,544 | -14,184 | -12,986 | -5,929 | -17,526 |
| Other Operating Activity | 16,765 | 2,140 | 6,899 | -2,458 | 3,498 |
| Operating Cash Flow | $109,392 | $93,514 | $74,303 | $71,097 | $38,470 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 6,609 | N/A | N/A | N/A |
| PPE Investments | -37,964 | -16,974 | -20,297 | -13,803 | -7,912 |
| Purchase Of Investment | N/A | N/A | -6,609 | N/A | N/A |
| Purchase Sale Intangibles | -13,501 | -4,677 | -1,327 | -14,059 | -425 |
| Other Investing Activity | -51,792 | -3,042 | 1,338 | -12,950 | 785 |
| Investing Cash Flow | $-89,756 | $-13,408 | $-25,568 | $-26,753 | $-7,127 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 15,771 | 44,500 | 9,693 | 11,076 | 18,595 |
| Debt Issued | N/A | 70,000 | 30,000 | 0 | N/A |
| Debt Repayment | -66,300 | -33,700 | 0 | 0 | N/A |
| Common Stock Issued | 7,746 | 3,860 | 5,394 | 5,227 | 300 |
| Common Stock Repurchased | 80,584 | -36,788 | -29,594 | 0 | N/A |
| Dividend Paid | -3,691 | -8,847 | -16,931 | -7,121 | -10,490 |
| Other Financing Activity | 17,470 | -181,854 | -37,087 | -14,287 | -18,482 |
| Financing Cash Flow | $51,580 | $-142,828 | $-38,525 | $-5,104 | $-10,077 |
| Exchange Rate Effect | -7,098 | -597 | 4,318 | 957 | 3,204 |
| Beginning Cash Position | 80,820 | 144,139 | 129,609 | 89,412 | 64,941 |
| End Cash Position | 144,938 | 80,820 | 144,139 | 129,609 | 89,412 |
| Net Cash Flow | $64,118 | $-63,318 | $14,529 | $40,198 | $24,471 |
| Free Cash Flow | |||||
| Operating Cash Flow | 109,392 | 93,514 | 74,303 | 71,097 | 38,470 |
| Capital Expenditure | -38,791 | -17,194 | -20,492 | -13,886 | -7,969 |
| Free Cash Flow | 70,601 | 76,320 | 53,811 | 57,211 | 30,501 |